# Contact | Semaglutide Telehealth Digest

> Contact the editors of Semaglutide Telehealth Digest about the published research we summarize. We are an editorial publisher — not a clinic, not a vendor, and we offer no medical advice.

Corrections, source suggestions, and editorial questions — we read them all.

## What we can help with

This is an editorial publisher, so the contact form is for editorial matters: a correction to a figure, a citation that needs fixing, a newly published trial you think we should summarize, or a question about how we read a particular study. If you spot a number on this site that doesn't match its source, tell us — accuracy is the whole point, and we want to know.

What we cannot help with is anything clinical. We cannot answer questions about your own health, recommend a dose, comment on whether semaglutide is right for you, or help you obtain it. We are not a clinic, we have no clinicians, and we sell nothing. Questions like those belong with a licensed healthcare professional who knows your history.

## Send a message

Use the form below to reach the editors. We read every message and prioritize corrections and source suggestions. Please don't include personal health information — this is an editorial inbox, not a medical one, and we're not able to act on clinical details.

---

A data-forward reading of the semaglutide trial ledger, posted head-to-head against tirzepatide — every figure reconciled to its study, with no clinic at the desk and nothing here dosed or sold.